Incessant ovulation and ovarian cancer - a hypothesis re-visited

被引:0
|
作者
Fathalla, M. F. [1 ]
机构
[1] Assiut Univ, Obstet & Gynaecol, PO 30, Assiut, Egypt
关键词
Incessant ovulation; prevention; oral contraception; ovarian cancer;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian cancer continues to be a silent killer. Most women have advanced disease at the time of diagnosis. Intensive efforts to develop effective screening strategies have not so far met with success. There is a need to re-visit the potential of prevention strategies. In 1971, the author submitted a hypothesis for a possible relationship between incessant ovulation and development of epithelial ovarian cancer. Subsequent research from different disciplines opened new frontiers to be explored for prevention in the general population and in high-risk groups, and for opportunistic interventions. The protective effect of oral contraceptive pills has been well documented. Widespread use of the pill in the past several decades is credited with a fall in the incidence of ovarian cancer in the general population, countering the effect of low parity. Removing the barriers against contraceptive access and satisfying the still unmet contraceptive need could expand the protective coverage. Enhanced understanding of the biological mechanisms involved in process of ovulation offers the promise of non-hormonal pharmacologic suppression of follicle rupture for women who have risk factors and do not need contraception. The evidence for a possible origin of epithelial cancer in the fimbria of the Fallopian tube presents an opportunity for preventive intervention, during hysterectomy, where salpingectomy alone may provide protection while one or both ovaries are conserved. Finally, the incessant ovulator egg-laying hen has demonstrated its potential as an experimental model for chemoprevention of epithelial ovarian cancer.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 50 条
  • [41] Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
    Asare, Amma
    Previs, Rebecca Ann
    Spinosa, Daniel
    Fellman, Bryan
    Scott, Amelia L.
    Mulder, Isabelle
    Mahmoud, Y.
    Enbaya, Ahmed
    Siedel, Jean Hansen
    Cobb, Lauren
    Solima, Pamela T.
    Sood, Anil K.
    Coleman, Robert L.
    Secord, Angeles Alvarez
    Westin, Shannon N.
    GYNECOLOGIC ONCOLOGY, 2025, 194 : 112 - 118
  • [42] Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate
    Vorwergk, J.
    Radosa, M. P.
    Nicolaus, K.
    Baus, N.
    Cruz, J. Jimenez
    Rengsberger, M.
    Gajda, M.
    Diebolder, H.
    Runnebaum, I. B.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 859 - 865
  • [43] "I just re-evaluated what was beautiful when I went through treatment:" an analysis of Elly Mayday's ovarian cancer narrative
    Tetteh, Dinah A.
    FEMINIST MEDIA STUDIES, 2022, 22 (08) : 1853 - 1868
  • [44] Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
    Lee, Yong Jae
    Chung, Young Shin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    EJSO, 2019, 45 (04): : 644 - 649
  • [45] 188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
    Chang, Chia-Ming
    Lan, Keng-Li
    Huang, Wen-Sheng
    Lee, Yi-Jang
    Lee, Te-Wei
    Chang, Chih-Hsien
    Chuang, Chi-Mu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [46] δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis
    Fontana, Fabrizio
    Marzagalli, Monica
    Raimondi, Michela
    Zuco, Valentina
    Zaffaroni, Nadia
    Limonta, Patrizia
    CELL PROLIFERATION, 2021, 54 (11)
  • [47] 1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
    Huihan Ma
    Qian Qin
    Jiaqing Mi
    Qinmei Feng
    BMC Pharmacology and Toxicology, 21
  • [48] 1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
    Ma, Huihan
    Qin, Qian
    Mi, Jiaqing
    Feng, Qinmei
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [49] Re-Interpretation of the Single Nucleotide Polymorphism in the Extracellular Domain of Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor at Nucleotide 626 among Ovarian Cancer Patients in Pakistani Population
    Mansoor, Qaisar
    Rehman, Abdul
    Farooqi, Ammad Ahmad
    Fayyaz, Sundas
    Ismail, M.
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (02): : 484 - 485
  • [50] The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models
    Stasiak, Piotr
    Sopel, Justyna
    Lipowicz, Julia Maria
    Rawluszko-Wieczorek, Agnieszka Anna
    Korbecki, Jan
    Januchowski, Radoslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)